Sachi Horibata , PhD
Education
PhD, Biological and Biomedical Sciences, Cornell University, 2010
Publications
The Evolving AML Genomic Landscape: Therapeutic Implications. Current cancer drug targets (2020)
Mycoplasma Infection Mediates Sensitivity of Multidrug-Resistant Cell Lines to Tiopronin: A Cautionary Tale. Journal of medicinal chemistry (2020)
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients. Molecular & cellular oncology (2019)
Heterogeneity in refractory acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America (2019)
A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancer. PloS one (2018)
ER-positive breast cancer cells are poised for RET-mediated endocrine resistance. PloS one (2018)
PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors. Cell and tissue research (2017)
Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration. BMC cancer (2017)
A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human. Cell (2016)
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. Journal of visualized experiments : JoVE (2015)
